Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer immunogene therapy.

H Yoshizawa1, H Kagamu, F Gejyo

  • 1Department of Medicine (II), Niigata University Medical School, Japan. nnys@med.niigata-u.ac.jp

Archivum Immunologiae Et Therapiae Experimentalis
|January 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase II study of daily carboplatin plus irradiation followed by durvalumab therapy for older adults (≥75 years) with unresectable III non-small-cell lung cancer and performance status of 2: NEJ039A.

ESMO open·2024
Same author

Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab.

Annals of hematology·2019
Same author

Unilateral flapping tremor associated with internal carotid artery stenosis: -A subtype of limb shaking.

European journal of neurology·2018
Same author

Successful perioperative haemostatic management of aortic coarctation in a 5-week-old infant with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia·2017
Same author

The basolateral nucleus of the amygdala mediates caloric sugar preference over a non-caloric sweetener in mice.

Neuroscience·2015
Same author

Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

Cancer immunotherapy shows promise as tumor cells can be modified to enhance immune recognition. Advances in tumor immunology and gene therapy are paving the way for novel cancer treatments, though challenges remain for existing tumors.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cancer development involves evading growth control and immune detection, leading to poorly immunogenic tumor cells.
  • Recent advances in identifying tumor antigens and understanding immune recognition mechanisms offer new avenues for cancer immunotherapy.
  • Knowledge of cytokines, tumor antigen characterization, and T cell activation provides crucial insights into tumor immunology.

Purpose of the Study:

  • To review recent progress in cancer immunogene therapy.
  • To discuss the potential of genetically modified tumor cells as cancer vaccines.
  • To highlight the challenges and limitations in applying these strategies to treat existing tumors.

Main Methods:

  • Investigating the role of cytokines in immune response regulation.

Related Experiment Videos

  • Molecular characterization of tumor antigens in mouse and human cancers.
  • Elucidating molecular mechanisms of T cell activation and antigen presentation.
  • Utilizing recombinant DNA technology to genetically modify tumor cells for therapeutic purposes.

    • Main Results:

    • Identification and characterization of tumor antigens have raised possibilities for immunotherapy.
    • Genetically modified tumor cells can be used as cellular vaccines to induce antitumor immunity in models.
    • Success has been observed in inducing antitumor immunity in some animal tumor models.

    Conclusions:

    • Cancer immunogene therapy, combining immunotherapy with genetically modified tumor cells, is a developing field.
    • Transferring genes to enhance cell immunogenicity can augment immune reactions against tumors.
    • Despite successes, significant difficulties and limitations exist in treating established cancers with these methods.